MANE

119.5203.92%
RW

Reid Waldman

Independent Director

Dr. Reid Waldman, M.D., serves as Director at AchieveRx, The Quit Company (formerly known as Achieve Life Sciences, Inc.) since May 29, 2026. He is co-founder and Director of VeraDermics, Inc. since October 2019 and has been its Chief Executive Officer since December 2022 and was its Chief Operating Officer. Under his stewardship, he has positioned Veradermics for rapid growth by implementing a differentiated strategy centered on advancing first-in-class therapeutics for under-innovated markets in dermatology. He has also successfully led the company through three equity financings raising proceeds of more than 38M and has advanced two Veradermics assets, VDPHL, a non-hormonal oral therapeutic into a first-in-human trial and VDMN, an immunostimulatory dissolvable microarray for the treatment of warts into a 150-subject, Phase 2 clinical trial. Dr. Waldman is a board-certified dermatologist with more than 10 years of clinical experience. Prior to founding Veradermics, Dr. Waldman was a prolific researcher authoring more than 100 publications including a textbook titled “Dermatology for the Primary Care Provider.” He has been the recipient of numerous accolades including the American Academy of Dermatology’s “Excellence in Patient Care” award. He earned his B.A. with Liberal Arts and his Medical Degree from the University of Missouri-Kansas City 6 Year BA/MD Program and completed his dermatology residency with a “Distinction in Clinical Trials” at the University of Connecticut.

Positions